TW269634B - - Google Patents

Info

Publication number
TW269634B
TW269634B TW081109192A TW81109192A TW269634B TW 269634 B TW269634 B TW 269634B TW 081109192 A TW081109192 A TW 081109192A TW 81109192 A TW81109192 A TW 81109192A TW 269634 B TW269634 B TW 269634B
Authority
TW
Taiwan
Prior art keywords
rgd
peptide
administered
containing peptide
microcapsules
Prior art date
Application number
TW081109192A
Other languages
English (en)
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of TW269634B publication Critical patent/TW269634B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TW081109192A 1991-11-07 1992-11-17 TW269634B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78923191A 1991-11-07 1991-11-07

Publications (1)

Publication Number Publication Date
TW269634B true TW269634B (zh) 1996-02-01

Family

ID=25146991

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109192A TW269634B (zh) 1991-11-07 1992-11-17

Country Status (8)

Country Link
US (1) US5629294A (zh)
EP (1) EP0667783B1 (zh)
AT (1) ATE179074T1 (zh)
AU (1) AU3064892A (zh)
DE (1) DE69229004D1 (zh)
TW (1) TW269634B (zh)
WO (1) WO1993008818A1 (zh)
ZA (1) ZA928607B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DE19529909C2 (de) * 1995-08-15 1998-04-09 Fresenius Ag Wässrige Spüllösung
EP0793965A3 (en) * 1996-02-29 1999-02-24 Tano, Yasuo Prophylactic/therapeutic composition for secondary cataract
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
WO2000004941A1 (en) * 1998-07-24 2000-02-03 Pharmacal Biotechnologies, Inc. Osseous tissue reconstruction system and method
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
JP2003500171A (ja) * 1999-06-01 2003-01-07 ブリストル−マイヤーズ スクイブ カンパニー より炎症性応答の少ないフィブリンシーラントおよびこれを用いる方法
AU2001236909A1 (en) * 2000-02-11 2001-08-20 Duke University Method of treating disorders of the eye
EP1845107B1 (en) * 2003-03-28 2019-05-29 FUJIFILM Manufacturing Europe B.V. Drug delivery system comprising RGD-enriched gelatine-like proteins with enhanced cell binding
WO2005053683A1 (en) * 2003-11-26 2005-06-16 Duke University A method of preventing or treating glaucoma
CN104174071A (zh) 2004-04-28 2014-12-03 安希奥设备国际有限责任公司 用于形成交联生物材料的组合物和系统及关联的制备方法与用途
EP1984391A4 (en) * 2006-01-19 2009-08-12 Eyegene Inc PEPTIDE-SUBSTANCED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES CONNECTED WITH THE VASCULAR SYSTEM
CN101379082A (zh) 2006-01-19 2009-03-04 爱吉恩公司 治疗血管相关疾病的包含肽的药物组合物
US9101581B2 (en) 2008-10-27 2015-08-11 Eyegene Inc. Method for treating vascular-related disease
AU2008303955A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of Pseudomonas aeruginosa infection
CA2698754A1 (en) * 2007-09-11 2009-03-19 Dorian Bevec Use of a peptide as a therapeutic agent
RU2010113971A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение пептида yy отдельно или в сочетании с глюкагоноподобным пептидом для применения в медицине
AU2008297899A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of human neuropeptide as a therapeutic agent
US20110250284A1 (en) * 2008-06-24 2011-10-13 Lavik Erin B Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
US9555071B2 (en) * 2012-06-13 2017-01-31 Thien Nguyen Methods and compositions for the treatment of axonal and neuronal degeneration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
DE3781263T2 (de) * 1986-12-15 1993-04-08 Inst Nat Sante Rech Med Peptid-derivate und deren verwendung in der therapie.
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
CA2008534A1 (en) * 1989-01-26 1990-07-26 Donald E. Ingber Method for inhibiting tumor recurrence after surgical resection
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
US5169833A (en) * 1989-12-15 1992-12-08 G. D. Searle & Co. Substituted cyclic pentapeptides

Also Published As

Publication number Publication date
DE69229004D1 (de) 1999-05-27
WO1993008818A1 (en) 1993-05-13
ATE179074T1 (de) 1999-05-15
US5629294A (en) 1997-05-13
EP0667783A4 (en) 1995-04-25
AU3064892A (en) 1993-06-07
EP0667783B1 (en) 1999-04-21
ZA928607B (en) 1993-06-07
EP0667783A1 (en) 1995-08-23

Similar Documents

Publication Publication Date Title
TW269634B (zh)
FI970522A (fi) Koostumukset ja menetelmät pidennetyn paikallisanestesian aikaansaamiseksi
CA2102429A1 (en) Bone growth factors and inhibitors of bone resorption for promoting bone formation
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
IL119627A0 (en) Controlled-release pharmaceutical preparations
CA2203033A1 (en) Compounds and compositions for delivering active agents
CA2271750A1 (en) Prolonged anesthesia in joints and body spaces
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
DE69705746D1 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
MD1558F2 (en) Method of prophylaxis of mammal acute renal insufficiency utilizing IGF-I insulin-like growth factor
GR3036798T3 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ATE167800T1 (de) Polymeres arzneimittelabgabesystem
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
TW228474B (zh)
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
ATE136773T1 (de) Kollagenmikrokapseln enthaltende injezierbare zusammensetzung
ATE289506T1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
Nawata et al. Bone Regeneration in Femoral Defect Filled with Fibrin Sealant. An Experimental Study
DE69927599D1 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
Alverdy et al. The effect of dietary glutamine on the mucosal immunoglobulin response
Kovács et al. Vasopressin and Hemostasis
Kreuz et al. Behandlung der Hemmkörperhämophilie im Kindesalter